SEC Form 4 · accession 0001127602-15-004636
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Feb 4, 2015
Accepted (ET)
Feb 5, 2015 · 6:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 4, 2015 | M | 2,211 | $63.22 | A | 2,351 | D | |
| Common StockF2 | Feb 4, 2015 | S | 611 | $139.9838 | D | 1,740 | D | |
| Common StockF3 | Feb 4, 2015 | S | 1,500 | $140.8171 | D | 240 | D | |
| Common StockF4 | Feb 5, 2015 | M | 5,547 | $30.75 | A | 5,787 | D | |
| Common StockF5 | Feb 5, 2015 | S | 3,610 | $140.844 | D | 2,177 | D | |
| Common StockF6 | Feb 5, 2015 | S | 1,637 | $141.4872 | D | 540 | D | |
| Common StockF4 | Feb 5, 2015 | M | 4,115 | $34.56 | A | 4,355 | D | |
| Common StockF7 | Feb 5, 2015 | S | 4,050 | $141.2729 | D | 305 | D | |
| Common StockF8 | Feb 5, 2015 | S | 300 | $142.39 | D | 240 | D | |
| Common Stock | Feb 5, 2015 | S | 65 | $141.2782 | D | 240 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse | |
| Common Stock | holding | — | — | — | 533,094 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $63.22 | Feb 4, 2015 | M | 2,211 | D | Dec 31, 2010 | Dec 31, 2020 | Common Stock | 2,211 | 448,852 | D |
| Stock OptionsF4 | $30.75 | Feb 5, 2015 | M | 5,547 | D | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 5,547 | 549,118 | D |
| Stock OptionsF4 | $34.56 | Feb 5, 2015 | M | 4,115 | D | Dec 30, 2005 | Dec 30, 2015 | Common Stock | 4,115 | 168,730 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2This transaction was executed in multiple trades at prices ranging from $139.67 to $140.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $140.30 to $141.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F5This transaction was executed in multiple trades at prices ranging from $140.21 to $141.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $141.21 to $141.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $140.5701 to $141.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $142.25 to $142.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.